ArticleJournal of hepatocellular carcinoma2022

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma.

Jin-Tao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.